T. Rowe Price Associates
CME icon

T. Rowe Price Associates’s CME Group CME Stock Holding History

T. Rowe Price Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42B Sell
4,812,056
-2,074,465
-30% -$616M 0.16% 122
2025
Q4 		$1.88B Sell
6,886,521
-474,687
-6% -$129M 0.2% 92
2025
Q3 		$1.99B Buy
7,361,208
+1,605,469
+28% +$437M 0.21% 83
2025
Q2 		$1.59B Buy
5,755,739
+307,429
+6% +$83.6M 0.18% 113
2025
Q1 		$1.45B Sell
5,448,310
-2,832,475
-34% -$699M 0.18% 110
2024
Q4 		$1.92B Buy
8,280,785
+3,921,278
+90% +$902M 0.22% 83
2024
Q3 		$962M Buy
4,359,507
+1,775,206
+69% +$367M 0.11% 174
2024
Q2 		$508M Sell
2,584,301
-360,636
-12% -$74.5M 0.06% 261
2024
Q1 		$634M Sell
2,944,937
-670,306
-19% -$141M 0.08% 235
2023
Q4 		$761M Buy
3,615,243
+1,048,511
+41% +$224M 0.1% 191
2023
Q3 		$514M Buy
2,566,732
+1,298,650
+102% +$258M 0.08% 229
2023
Q2 		$235M Sell
1,268,082
-120,997
-9% -$22.4M 0.03% 371
2023
Q1 		$266M Sell
1,389,079
-980,756
-41% -$177M 0.04% 333
2022
Q4 		$399M Sell
2,369,835
-86,347
-4% -$15M 0.06% 269
2022
Q3 		$435M Sell
2,456,182
-1,934,128
-44% -$382M 0.07% 244
2022
Q2 		$899M Sell
4,390,310
-3,409,694
-44% -$723M 0.11% 195
2022
Q1 		$1.86B Buy
7,800,004
+4,148,870
+114% +$974M 0.19% 108
2021
Q4 		$834M Buy
3,651,134
+174,062
+5% +$38.3M 0.08% 255
2021
Q3 		$672M Sell
3,477,072
-15,900
-0.5% -$3.22M 0.06% 297
2021
Q2 		$743M Buy
3,492,972
+434,854
+14% +$91.8M 0.07% 279
2021
Q1 		$625M Sell
3,058,118
-1,681,202
-35% -$331M 0.06% 298
2020
Q4 		$863M Sell
4,739,320
-2,229,203
-32% -$379M 0.09% 240
2020
Q3 		$1.17B Sell
6,968,523
-691,272
-9% -$116M 0.13% 161
2020
Q2 		$1.25B Buy
7,659,795
+1,945,913
+34% +$349M 0.16% 142
2020
Q1 		$988M Buy
5,713,882
+1,316,473
+30% +$262M 0.16% 138
2019
Q4 		$883M Sell
4,397,409
-31,481
-0.7% -$6.46M 0.11% 197
2019
Q3 		$936M Buy
4,428,890
+2,356,268
+114% +$492M 0.13% 169
2019
Q2 		$402M Sell
2,072,622
-139,478
-6% -$25.7M 0.06% 315
2019
Q1 		$364M Buy
2,212,100
+671,739
+44% +$119M 0.05% 318
2018
Q4 		$290M Sell
1,540,361
-575,357
-27% -$106M 0.05% 339
2018
Q3 		$360M Buy
2,115,718
+451,547
+27% +$76M 0.05% 346
2018
Q2 		$273M Buy
1,664,171
+318,103
+24% +$52M 0.04% 398
2018
Q1 		$218M Buy
1,346,068
+412,498
+44% +$65.7M 0.03% 441
2017
Q4 		$136M Sell
933,570
-72,263
-7% -$10.3M 0.02% 548
2017
Q3 		$136M Sell
1,005,833
-1,341,246
-57% -$169M 0.02% 536
2017
Q2 		$294M Sell
2,347,079
-981,169
-29% -$117M 0.05% 351
2017
Q1 		$395M Sell
3,328,248
-1,659,227
-33% -$200M 0.07% 276
2016
Q4 		$575M Buy
4,987,475
+58,816
+1% +$6.55M 0.11% 207
2016
Q3 		$515M Sell
4,928,659
-328,953
-6% -$34.3M 0.1% 225
2016
Q2 		$512M Buy
5,257,612
+482,330
+10% +$45.6M 0.11% 216
2016
Q1 		$459M Buy
4,775,282
+2,725,813
+133% +$248M 0.1% 235
2015
Q4 		$186M Sell
2,049,469
-206,118
-9% -$19.4M 0.04% 421
2015
Q3 		$209M Buy
2,255,587
+169,835
+8% +$16.1M 0.05% 403
2015
Q2 		$194M Buy
2,085,752
+305,260
+17% +$28.5M 0.04% 456
2015
Q1 		$169M Buy
1,780,492
+97,657
+6% +$9.05M 0.03% 473
2014
Q4 		$149M Buy
1,682,835
+150,060
+10% +$12.7M 0.03% 499
2014
Q3 		$123M Buy
1,532,775
+180,580
+13% +$13.6M 0.03% 545
2014
Q2 		$95.9M Sell
1,352,195
-261,115
-16% -$18.4M 0.02% 645
2014
Q1 		$119M Buy
1,613,310
+94,283
+6% +$7.11M 0.03% 584
2013
Q4 		$119M Sell
1,519,027
-500,910
-25% -$39.2M 0.03% 566
2013
Q3 		$149M Buy
2,019,937
+47,115
+2% +$3.47M 0.04% 475
2013
Q2 		$150M Buy
+1,972,822
New +$129M 0.04% 460

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

T. Rowe Price Associates's CME Position: Q1 2026 in Review

T. Rowe Price Associates reduced its CME Group (CME) stake by 30% in Q1 2026, selling an estimated $616M and leaving 4,812,056 shares worth $1.42B. The position accounts for 0.16% of the portfolio, ranked #122.

T. Rowe Price Associates first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.99B in Q3 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • T. Rowe Price Associates held 4,812,056 shares of CME Group worth $1.42B as of Q1 2026.
  • T. Rowe Price Associates sold 2,074,465 CME Group shares in Q1 2026, an estimated $616M.
  • CME Group made up 0.16% of T. Rowe Price Associates's portfolio in Q1 2026, its #122 holding.
  • T. Rowe Price Associates first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's CME Group position peaked at $1.99B in Q3 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.